Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sure looks like that...
LOL
$3.53 from February 24
$4.70 from January 02
I think there will be no change and no volume....
(Markets are close in the US)
Hard to say ....
Not really watching it those days, but I think the cycle will continue (price jump and raise money then price fall)
If i was holding, I would have sell 30-50% on any spike and buy back later if I would like to keep it.
I think there are better plays out there
Still around, but with small position and not tracking it as much as I used to.
I think probably the Yahoo board will give you better information (but I'm hardly reading it either)
Good luck
Same as previous runs...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142248871
People are not learning
And here we go again.....LOL
Sunwolf
Don't give up on the stock market, but make sure you have an exit plans and follow them.
We all lost money on stocks (and biotech were the worst over last several month), so make sure to diversify and cut losses early (and I need to learn to do the same)
Happy Holidays and to a better 2019 (but the market can continue to be brutal....)
The entire bio sector got crashed and the small ones got crashed the most.
Better to be on the sideline until the air is clear
:o))
We might be close, but not yet
All I see is all time low and probably going lower towards the next reverse split
Best of luck and make sure to sell the spikes
Did you at least sell???
Nope, only when lower....
The answer fits the "question"
You posting blurbs without understanding the target market and current state of this field.
ATRS will not double overnight, due to over 150 million shares which gives it MC of around 600mm at this price.
BUT the approval might very well generate income that will push them to the next level.
And there is more
Maybe
:o)
Sorry you got rejected
Hope you have better luck next time...
:o))
How about phase 2&3 first?
It's not paper work that will ship it, it's FDA approval....
In about 5 years....
:o)
They already jumped in....and drowned
??
Too many p1 cohorts
Need to start p2....before the next reverse split.
Sunofwolf.
I got beach property in Arizona for sale
Special price just for you....
You will never learn, will you?
My name is still in the moderator list, but not active as one....
Let you guys have all the fun for your selves.....
There are many other stocks out there with better management and better chance to deliver
Will keep watching thou
They just diluted by more than 100% like they already did multiple times over the last 5 years (3 RS and counting)
5 years chart
This stock is for trade only, I was trying to short after the RS but there were no shares available at 3 brokers (my guess is that the financiers shorted ahead of the placement and will cover with new shares)
There are many better stocks with better management out there .
There would be more runs coming, try to sell and either trade, or don't look back.
Good luck
My twitter guess of $3 placement was closer.
Now time to guess when is the next RS ???
If they can continue showing this kind of results (in more than one patient), they should be able to sign a good deal with upfront money (or at this market cap, straight buyout)
They are not there yet, so treat them as a gamble if you are long
But still nice news.
My guess is placement today after the close in the $5-$7 area.
The money people are using this run to short against their new shares...
Just IMHO
No position, but I follow the stock.
Very interesting share holders vote (8K)
Board of directors don't get much confidence from this vote
Here are the news (Orphan designation):
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=646918
Just a reminder.....sell the news.....
Yep, just don't overstay your welcome....
Just look at the 5 year chart, the best sky slop you have ever seen.
This is going to the 4th or 5th RS and will continue until people will realize this company will not make money on technology, but on repeat offering.
If you look on previous placements, you'll see multiple runs a few weeks before, to enable the financier to short ahead of the placement.
There will be runs before next RS, but I think it will be more than 1:25.....
Make sure to sell on any run (like the ones 2 weeks ago)
You better wait for the placement and Reverse Split, before throwing any money here.
And even then, just for trade with stops.
If trial results are good, 2019 might be a breakout year.
But we need full P2 data on many more patients and they need money for that.
At current cash position, they can't really negotiate....
I'm not sure what the outcome will be, but I don't think they can do it on their own.
This is a plan forward, but I don't think it will take long.
They need to raise money ASAP and if they do before RS, stock price will reflect it and RS will be needed.
Or they can do the RS and then sell shares right away (will be major dilution, due to low number of shares and the need for money)
So - Catch22 so far and better to watch from the side and see how thing develop.
They had 1:20 around 2014 and 1:10 around 2016, so they already know how to play the game.....
I don't think so:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=140820832
Same as your past posts.....
I won't worry so much about the 1 million shares incentive.
They are usually given to employees and vested over several years, so won't hit the market anytime soon (not all of it)
But they do need to raise more money.....
With less than 2 Q's of cash, they will have to raise money soon.
They are increasing expenses for trials and can't wait for last minute to get the money
CNN article:
https://www.cnn.com/2018/04/09/health/parkinsons-drug-nuplazid-invs/index.html
And ACAD response:
https://www.documentcloud.org/documents/4433424-ACADIA-Response.html
I'll stay away.....(and looks like BB lost their magic touch)
I think I heard it before......
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=130114426